American International Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-62,705
| Closed | -$213K | – | 3115 |
|
|
2018
Q3 | $213K | Buy |
62,705
+1,129
| +2% | +$3.84K | ﹤0.01% | 2386 |
|
|
2018
Q2 | $232K | Buy |
61,576
+4,327
| +8% | +$16.3K | ﹤0.01% | 2270 |
|
|
2018
Q1 | $234K | Sell |
57,249
-3,078
| -5% | -$12.6K | ﹤0.01% | 2173 |
|
|
2017
Q4 | $281K | Buy |
60,327
+5,484
| +10% | +$25.5K | ﹤0.01% | 2112 |
|
|
2017
Q3 | $389K | Buy |
54,843
+4,101
| +8% | +$29.1K | ﹤0.01% | 1907 |
|
|
2017
Q2 | $367K | Buy |
50,742
+2,120
| +4% | +$15.3K | ﹤0.01% | 1909 |
|
|
2017
Q1 | $300K | Buy |
48,622
+3,220
| +7% | +$19.9K | ﹤0.01% | 1929 |
|
|
2016
Q4 | $266K | Sell |
45,402
-118
| -0.3% | -$691 | ﹤0.01% | 2011 |
|
|
2016
Q3 | $242K | Buy |
45,520
+69
| +0.2% | +$366 | ﹤0.01% | 2041 |
|
|
2016
Q2 | $301K | Sell |
45,451
-49,951
| -52% | -$331K | ﹤0.01% | 1877 |
|
|
2016
Q1 | $445K | Sell |
95,402
-1,544
| -2% | -$7.2K | ﹤0.01% | 2091 |
|
|
2015
Q4 | $489K | Sell |
96,946
-4,248
| -4% | -$21.4K | ﹤0.01% | 2056 |
|
|
2015
Q3 | $356K | Sell |
101,194
-348
| -0.3% | -$1.22K | ﹤0.01% | 2310 |
|
|
2015
Q2 | $1.01M | Sell |
101,542
-2,735
| -3% | -$27.3K | ﹤0.01% | 1573 |
|
|
2015
Q1 | $1.33M | Buy |
104,277
+18,500
| +22% | +$236K | 0.01% | 1413 |
|
|
2014
Q4 | $1.21M | Sell |
85,777
-5,097
| -6% | -$72.1K | 0.01% | 1422 |
|
|
2014
Q3 | $1.25M | Buy |
90,874
+14,590
| +19% | +$201K | 0.01% | 1387 |
|
|
2014
Q2 | $1.17M | Buy |
76,284
+14,258
| +23% | +$219K | 0.01% | 1459 |
|
|
2014
Q1 | $1.06M | Buy |
62,026
+3,094
| +5% | +$52.7K | 0.01% | 1483 |
|
|
2013
Q4 | $763K | Sell |
58,932
-4,244
| -7% | -$55K | ﹤0.01% | 1687 |
|
|
2013
Q3 | $638K | Sell |
63,176
-1,584
| -2% | -$16K | ﹤0.01% | 1772 |
|
|
2013
Q2 | $484K | Buy |
+64,760
| New | +$484K | ﹤0.01% | 1872 |
|